1. Home
  2. ATHE vs OXBR Comparison

ATHE vs OXBR Comparison

Compare ATHE & OXBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATHE
  • OXBR
  • Stock Information
  • Founded
  • ATHE 1997
  • OXBR 2013
  • Country
  • ATHE Australia
  • OXBR Cayman Islands
  • Employees
  • ATHE N/A
  • OXBR N/A
  • Industry
  • ATHE Biotechnology: Pharmaceutical Preparations
  • OXBR Property-Casualty Insurers
  • Sector
  • ATHE Health Care
  • OXBR Finance
  • Exchange
  • ATHE Nasdaq
  • OXBR Nasdaq
  • Market Cap
  • ATHE 21.4M
  • OXBR 24.5M
  • IPO Year
  • ATHE N/A
  • OXBR 2014
  • Fundamental
  • Price
  • ATHE $4.75
  • OXBR $4.25
  • Analyst Decision
  • ATHE Strong Buy
  • OXBR
  • Analyst Count
  • ATHE 2
  • OXBR 0
  • Target Price
  • ATHE $8.00
  • OXBR N/A
  • AVG Volume (30 Days)
  • ATHE 1.3M
  • OXBR 32.7K
  • Earning Date
  • ATHE 02-15-2025
  • OXBR 03-25-2025
  • Dividend Yield
  • ATHE N/A
  • OXBR N/A
  • EPS Growth
  • ATHE N/A
  • OXBR N/A
  • EPS
  • ATHE N/A
  • OXBR N/A
  • Revenue
  • ATHE $2,681,669.00
  • OXBR N/A
  • Revenue This Year
  • ATHE N/A
  • OXBR N/A
  • Revenue Next Year
  • ATHE N/A
  • OXBR N/A
  • P/E Ratio
  • ATHE N/A
  • OXBR N/A
  • Revenue Growth
  • ATHE 2.63
  • OXBR N/A
  • 52 Week Low
  • ATHE $1.00
  • OXBR $0.87
  • 52 Week High
  • ATHE $5.87
  • OXBR $5.05
  • Technical
  • Relative Strength Index (RSI)
  • ATHE 75.45
  • OXBR 53.03
  • Support Level
  • ATHE $2.76
  • OXBR $4.37
  • Resistance Level
  • ATHE $5.14
  • OXBR $4.74
  • Average True Range (ATR)
  • ATHE 0.42
  • OXBR 0.41
  • MACD
  • ATHE 0.15
  • OXBR -0.02
  • Stochastic Oscillator
  • ATHE 71.14
  • OXBR 52.11

About ATHE Alterity Therapeutics Limited

Alterity Therapeutics Ltd is active in the healthcare domain. The company is engaged in research collaborations for the treatment of Parkinsonian movement disorders, Alzheimer's disease, Huntington disease, and other neurodegenerative disorders. The company's drug candidate-PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. It has a drug candidate for Parkinson's disease and other movement disorders (ATH434). The Group operated in one segment, being researching and developing Parkinsonian and other neurodegenerative disorders.

About OXBR Oxbridge Re Holdings Limited

Oxbridge Re Holdings Ltd is a specialty property and casualty reinsurer. It provides reinsurance solutions through its subsidiary. It focuses on underwriting fully collateralized reinsurance contracts primarily for property and casualty insurance companies in the Gulf Coast region of the United States, with an emphasis on Florida. Oxbridge specializes in underwriting medium frequency, high severity risks, where insufficient data exists to analyze effectively the risk/return profile of reinsurance contracts. The Company manages its business on the basis of one operating segment, Property and Casualty Reinsurance.

Share on Social Networks: